Junxia Chen

#1 Yixueyuan Road
Chongqing, 400016, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Correction: The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.

Correction: The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.

Journal: Molecular cancer

Published: February 17, 2026

A novel protein cPFKFB4 encoded by hsa_circ_0065394 strengthens PKM2-mediated glucose metabolic reprogramming to facilitate pancreatic cancer progression under hypoxia.

A novel protein cPFKFB4 encoded by hsa_circ_0065394 strengthens PKM2-mediated glucose metabolic reprogramming to facilitate pancreatic cancer progression under hypoxia.

Journal: Molecular cancer

Published: May 06, 2025

Retraction Note to: The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.

Retraction Note to: The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.

Journal: Molecular cancer

Published: July 08, 2022

Corrigendum to "lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA" [Biochim. Biophys. Acta Mol. Cell Res. 1864 (2017) 1887-1899/BBAMCR-17-151R2].

Corrigendum to "lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA" [Biochim. Biophys. Acta Mol. Cell Res. 1864 (2017) 1887-1899/BBAMCR-17-151R2].

Journal: Biochimica et biophysica acta. Molecular cell research

Published: May 09, 2022

Corrigendum to "Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway" [Cancer Letter 403(2017) 305-317].

Corrigendum to "Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway" [Cancer Letter 403(2017) 305-317].

Journal: Cancer letters

Published: March 18, 2022

Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10.

Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10.

Journal: Molecular cancer

Published: December 13, 2021

The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.

The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.

Journal: Molecular cancer

Published: February 06, 2021

The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.

The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.

Journal: Molecular cancer

Published: November 01, 2019

The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.

The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.

Journal: Molecular cancer

Published: September 28, 2018

lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.

lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: March 14, 2017

Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.

Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.

Journal: Cancer letters

Published: March 01, 2017

Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.

Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 11, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026